View in EDS HTML Full Text PDF Full Text

A phase 4, open-label study to evaluate the safety and immunogenicity of DTaP5-HBV-IPV-Hib in children previously vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hib (V419-016).

Saved in:
Bibliographic Details
Title: A phase 4, open-label study to evaluate the safety and immunogenicity of DTaP5-HBV-IPV-Hib in children previously vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hib (V419-016).
Authors: Guerra A; Research, MSD (UK) Limited, London, UK., Costantino C; Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Excellence Specialties, University of Palermo, Palermo, Italy., Martinon-Torres F; Translational Pediatrics and Infectious Diseases, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain.; GENVIP Research Group (www.genvip.eu), Instituto de Investigación Sanitaria de Santiago, Universidad de Santiago de Compostela, Santiago de Compostela, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain., Westerholt S; Pediatrics, Praxis für Kinder- und Jugendmedizin, Wolfsburg, Germany., Lambeth C; Research, Merck & Co., Inc., Rahway, USA., Chen Z; Research, Merck & Co., Inc., Rahway, USA., Lumley J; Research, Merck & Co., Inc., Rahway, USA., Marcek T; Vaccine, MCM Vaccine B.V, Leiden, Netherlands., Johnson D; Vaccine, Sanofi Vaccines, Swiftwater, USA., Wilck M; Research, Merck & Co., Inc., Rahway, USA.
Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2310900. Date of Electronic Publication: 2024 Feb 08.
Publication Type: Clinical Trial, Phase IV; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38327239
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A phase 4, open-label study to evaluate the safety and immunogenicity of DTaP5-HBV-IPV-Hib in children previously vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hib (V419-016).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Guerra+A%22">Guerra A</searchLink>; Research, MSD (UK) Limited, London, UK.<br /><searchLink fieldCode="AU" term="%22Costantino+C%22">Costantino C</searchLink>; Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Excellence Specialties, University of Palermo, Palermo, Italy.<br /><searchLink fieldCode="AU" term="%22Martinon-Torres+F%22">Martinon-Torres F</searchLink>; Translational Pediatrics and Infectious Diseases, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain.; GENVIP Research Group (www.genvip.eu), Instituto de Investigación Sanitaria de Santiago, Universidad de Santiago de Compostela, Santiago de Compostela, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Westerholt+S%22">Westerholt S</searchLink>; Pediatrics, Praxis für Kinder- und Jugendmedizin, Wolfsburg, Germany.<br /><searchLink fieldCode="AU" term="%22Lambeth+C%22">Lambeth C</searchLink>; Research, Merck & Co., Inc., Rahway, USA.<br /><searchLink fieldCode="AU" term="%22Chen+Z%22">Chen Z</searchLink>; Research, Merck & Co., Inc., Rahway, USA.<br /><searchLink fieldCode="AU" term="%22Lumley+J%22">Lumley J</searchLink>; Research, Merck & Co., Inc., Rahway, USA.<br /><searchLink fieldCode="AU" term="%22Marcek+T%22">Marcek T</searchLink>; Vaccine, MCM Vaccine B.V, Leiden, Netherlands.<br /><searchLink fieldCode="AU" term="%22Johnson+D%22">Johnson D</searchLink>; Vaccine, Sanofi Vaccines, Swiftwater, USA.<br /><searchLink fieldCode="AU" term="%22Wilck+M%22">Wilck M</searchLink>; Research, Merck & Co., Inc., Rahway, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101572652%22">Human vaccines & immunotherapeutics</searchLink> [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2310900. <i>Date of Electronic Publication: </i>2024 Feb 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase IV; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101572652 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2164-554X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221645515%22">21645515 </searchLink><i>NLM ISO Abbreviation: </i>Hum Vaccin Immunother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38327239
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/21645515.2024.2310900
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2310900
    Titles:
      – TitleFull: A phase 4, open-label study to evaluate the safety and immunogenicity of DTaP5-HBV-IPV-Hib in children previously vaccinated with DTaP2-HBV-IPV-Hib or DTaP5-HBV-IPV-Hib (V419-016).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Guerra A
      – PersonEntity:
          Name:
            NameFull: Costantino C
      – PersonEntity:
          Name:
            NameFull: Martinon-Torres F
      – PersonEntity:
          Name:
            NameFull: Westerholt S
      – PersonEntity:
          Name:
            NameFull: Lambeth C
      – PersonEntity:
          Name:
            NameFull: Chen Z
      – PersonEntity:
          Name:
            NameFull: Lumley J
      – PersonEntity:
          Name:
            NameFull: Marcek T
      – PersonEntity:
          Name:
            NameFull: Johnson D
      – PersonEntity:
          Name:
            NameFull: Wilck M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 31
              M: 12
              Text: 2024 Dec 31
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2164-554X
          Numbering:
            – Type: volume
              Value: 20
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Human vaccines & immunotherapeutics
              Type: main
ResultId 1